Do cardiovascular risk factors in polycystic ovarian syndrome result in more cardiovascular events?

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 4, 2008, Pages 1170-1171

  Guzick, David S ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HOMOCYSTEINE;

ANDROGEN SYNTHESIS; ANGIOCARDIOGRAPHY; ANOVULATION; CARDIOVASCULAR RISK; DYSLIPIDEMIA; EDITORIAL; FEMALE; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL; UNITED KINGDOM;

EID: 42049098429     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-0288     Document Type: Editorial

References (17)

1. Shaw LJ, Bairey Merz CN, Azziz R, Stanczyk FZ, Sopko G, Braunstein GD, Kelsey SF, Kip KE, Cooper-DeHoff RM, Johnson BD, Vaccarino V, Reis SE, Bittner V, Hodgson TK, Rogers W, Pepine CJ 2008 Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health - National Heart, Lung, and Blood Institute (NHLBI)-sponsored Women's Ischemia Syndrome Evaluation (WISE). J Clin Endocrinal Metab 93:1276-1284
2. Legro RS, Kunselman AR, Dodson WC, Dunaif A 1999 Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective controlled study in 254 affected women. J Clin Endocrinol Metab 84:165-169
3. Talbott EO, Zborowski JV, Sutton-Tyrrell K, McHugh-Pemu KP, Guzick DS 2001 Cardiovascular risk in women with polycystic ovary syndrome. Obset Gynecol Clin North Am 28:111-133
4. Legro RS 2001 Diabetes prevalence and risk factors in polycystic ovarian syndrome. Obstet Gynecol Clin North Am 28:99-109
5. Dunaif A, Segal KR, Futterweit W, Dobrjansky A 1989 Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38:1165-1174
6. Talbott EO, Guzick DS, Clerici A, Berga S, Detre K, Weimer K, Kuller L 1995 Coronary heart disease risk factors in women with polycystic ovary syndrome. Arterioscler Thromb Vasc Biol 15:821-826
7. Kelly CC, Lyall H, Petrie JR, Gould GW, Connell JM, Sattar N 2001 Low-rade chronic inflammation in women with polycystic ovarian syndrome. J Clin Endocrinol Metab 86:2453-2455
8. Schachter M, Raziel A, Friedler S, Strassburger D, Bern O, Ron-El R 2003 Insulin resistance in patients with polycystic ovary syndrome is associated with elevated plasma homocysteine. Hum Reprod 18:721-727
9. Talbott EO, Guzick DS, Sutton-Tyrrell K, McHugh-Pemu K, Zborowski J, Remsberg K, Kuller L 2000 Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women. Arterioscler Thromb Vasc Biol 20:2414-2421
10. Talbott EO, Zborowski JV, Rager JR, Boudreaux MY, Edmundowicz DA, GuzickDS2004 Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome. J Clin Endocrinol Metab 89:5454-5461
11. Christian RC, Dumesic DA, Behrenbeck T, Oberg A, Sheedy PF, Fitzpatick L 2003 Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome. J Clin Endocrinol Metab 88:2562-2568
12. Battaglia C, Mancini F, Cianciosi A, Busacchi P, Facchinetti F, Marchesini GR, Marzocchi R, de Aloysio D 2008 Vascular risk in young women with polycystic ovary and polycystic ovary syndrome. Obstet Gynecol 111:385-395
13. Orio F, Palomba S, Spinelli, Cascella T, Tauchmanova L, Zullo F, Lombardi G, Colao A 2004 The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study. J Clin Endocrinol Metab 89:3696-3701
14. Apridonidze T, Essah PA, Iurono MJ, Nestler JE 2005 Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 90:1929-1935
15. Talbott EO, Zborowski JV, Boudraux M 2004 Do women with polycystic ovary syndrome have an increased risk of cardiovascular disease? Review of the evidence. Minerva Ginecol 56:27-39
16. Cibula D, Cifkova R, Fanta M, Poledne R, Zivny J, Skibova J 2000 Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome. Hum Reprod 15:785-789
17. Pierpoint R, McKeigue PM, Isaacs AJ, Wild SH, Jacobs HS 1998 Mortality of women with polycystic ovary syndrome at long-term follow-up. J Clin Epidemiol 51:581-586